Jakavi (ruxolitinib) 20 mg film-coated tablets, 56 tablets — original (Novartis, Switzerland) Treatment of diseases associated with splenomegaly or symptoms of primary myelofibrosis Targeted cancer therapy. Drug delivery from Europe. +380996042415 Viber, WhatsApp
Delivery methods
- Delivery to Istanbul
Delivery time
- 7-10 days
Payment methods
- Payment to the account after receipt
Indications
- Treatment of diseases associated with splenomegaly or symptoms of primary myelofibrosis (also known as chronic idiopathic myelofibrosis) in adult patients, myelofibrosis due to polycythemia vera, or myelofibrosis due to essential thrombocythemia.
- Trade Name:Jakavi
- Chemical Name:Ruxolitinib
- Dosage:15 mg
- Quantity:56
- Form of Issue:Tablets
- currency:4
No reviews yet